Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
25 pending office actions • 25 art units • 24 examiners • 0 of 25 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days
The Board of Regents of the University of Oklahoma has 25 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 24 distinct examiners and 25 distinct art units, indicating a large portfolio with nearly complete distribution across examination assignments.
TAN, DING Y is the busiest examiner, with 2 pending office actions. The limited concentration at that examiner means counsel cannot rely on a single prosecution pattern for the portfolio as a whole.
The art-unit distribution calls for application-level docket control, separate prior-art assessments, and careful tracking of written-description and enablement positions. A central prosecution review can promote consistency in scientific terminology while allowing each response to reflect its assigned examiner and art unit.
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (16%) |
| §103 only | 8 (32%) |
| §112 only | 1 (4%) |
| Double-patenting only | 1 (4%) |
| Double-patenting + other | 1 (4%) |
| Multi-statute (no §101) | 10 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TAN, DING Y | 2 | 76.2% | +17.6% |
| MCCULLOUGH, ERIC J. | 1 | 31.9% | +43.1% |
| GUAN, GUANG H | 1 | 59.7% | +54.9% |
| CHOWDHURY, IQBAL HOSSAIN | 1 | 73.6% | +57.6% |
| MOSHER, ERIC PARKER | 1 | 100.0% | +0.0% |
| NEWAY, SAMUEL G | 1 | 75.1% | +6.4% |
| FERENCE, JAMES M | 1 | 71.2% | +16.8% |
| COUNTS, GARY W | 1 | 58.9% | +29.7% |
| DIETZ, NOE ROBERT | 1 | 0.0% | +0.0% |
| RAGHU, GANAPATHIRAM | 1 | 73.7% | +26.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18444665 | System and Method for Locating Undocumented Orphaned Oil and Gas Wells with a Smartphone | SCHINDLER, DAVID M | 155d overdue |
| 18873924 | ZINC IMIDAZOLE SALICYLALDOXIME-BASED ADSORPTIVE MEMBRANES FOR REMOVAL OF METAL IONS FROM AQUEOUS SOLUTIONS | MCCULLOUGH, ERIC J. | 42d overdue |
| 18037706 | Apparatus and Method for Capturing Aerosols | WILSON, KAYLEE R | 15d overdue |
| 17971072 | MICROBIOME TRANSPLANTATION FOR OSTEOARTHRITIS THERAPY | CRUM, MARY ABOU NADER | 34d |
| 18904698 | SYSTEM FOR MOUNTING SOLAR PANELS | TAN, DING Y | 62d |
| 18921938 | THERAPEUTIC AND IMAGING AGENTS FOR TARGETING MYOCARDIAL TISSUE | MOSHER, ERIC PARKER | — |
| 18854412 | CLINICALLY TRAINED ARTIFICIAL INTELLIGENCE ADVANCED TUMOR MANAGEMENT SYSTEM | NEWAY, SAMUEL G | — |
| 18823394 | COMPOSITE CONCRETE STEEL COLUMN HAVING A FULLY- EMBEDDED X-SHAPE STEEL SECTION | FERENCE, JAMES M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18873924 | ZINC IMIDAZOLE SALICYLALDOXIME-BASED ADSORPTIVE MEMBRANES FOR REMOVAL OF METAL IONS FROM AQUEOUS SOLUTIONS | MCCULLOUGH, ERIC J. | 42d overdue |
| 18904698 | SYSTEM FOR MOUNTING SOLAR PANELS | TAN, DING Y | 62d |
| 19016472 | SPRING CLAMPS AND RELATED METHODS FOR CLAMPING FORCE DISTRIBUTION AND RETENTION | TAN, DING Y | — |
| 18869695 | PHOTOVOLTAIC FASTENING SYSTEMS AND RELATED METHODS OF USE | GUAN, GUANG H | — |
| 18929841 | VARIANT ALICYCLOBACILLUS CAS12b PROTEINS WITH IMPROVED DNA CLEAVAGE SELECTIVITY AND METHODS OF USE | CHOWDHURY, IQBAL HOSSAIN | — |
| 18823394 | COMPOSITE CONCRETE STEEL COLUMN HAVING A FULLY- EMBEDDED X-SHAPE STEEL SECTION | FERENCE, JAMES M | — |
| 18840269 | PROTEIN BIOMARKERS OF INFLAMMATORY ACTIVITY IN MULTIPLE SCLEROSIS | COUNTS, GARY W | — |
| 18742139 | DRUG SCREENING METHOD AND MODEL FOR MONITORING PLATINUM-RESISTANT OVARIAN CANCER TUMOR GROWTH AND METASTASES | RAGHU, GANAPATHIRAM | — |
| Art Unit | Apps |
|---|---|
| 4100 | 1 |
| 1773 | 1 |
| 3631 | 1 |
| 1656 | 1 |
| 1612 | 1 |
| 3691 | 1 |
| 3632 | 1 |
| 3635 | 1 |
| 1678 | 1 |
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19016472 | SPRING CLAMPS AND RELATED METHODS FOR CLAMPING FORCE DISTRIBUTION AND RETENTION | TAN, DING Y | 4100 | §103 | Non-Final OA | — | Pending | Jan 10, 2025 |
| 18873924 | ZINC IMIDAZOLE SALICYLALDOXIME-BASED ADSORPTIVE MEMBRANES FOR REMOVAL OF METAL IONS FROM AQUEOUS SOLUTIONS | MCCULLOUGH, ERIC J. | 1773 | §103§112 | Final Rejection | 42d overdue | Pending | Dec 11, 2024 |
| 18869695 | PHOTOVOLTAIC FASTENING SYSTEMS AND RELATED METHODS OF USE | GUAN, GUANG H | 3631 | §112 | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18929841 | VARIANT ALICYCLOBACILLUS CAS12b PROTEINS WITH IMPROVED DNA CLEAVAGE SELECTIVITY AND METHODS OF USE | CHOWDHURY, IQBAL HOSSAIN | 1656 | DP | Non-Final OA | — | Pending | Oct 29, 2024 |
| 18921938 | THERAPEUTIC AND IMAGING AGENTS FOR TARGETING MYOCARDIAL TISSUE | MOSHER, ERIC PARKER | 1612 | §103§112 | Non-Final OA | — | Pending | Oct 21, 2024 |
| 18854412 | CLINICALLY TRAINED ARTIFICIAL INTELLIGENCE ADVANCED TUMOR MANAGEMENT SYSTEM | NEWAY, SAMUEL G | 3691 | §101§103§112 | Non-Final OA | — | Pending | Oct 04, 2024 |
| 18904698 | SYSTEM FOR MOUNTING SOLAR PANELS | TAN, DING Y | 3632 | §102§112 | Non-Final OA | 62d | Pending | Oct 02, 2024 |
| 18823394 | COMPOSITE CONCRETE STEEL COLUMN HAVING A FULLY- EMBEDDED X-SHAPE STEEL SECTION | FERENCE, JAMES M | 3635 | §102§103§112 | Non-Final OA | — | Pending | Sep 03, 2024 |
| 18840269 | PROTEIN BIOMARKERS OF INFLAMMATORY ACTIVITY IN MULTIPLE SCLEROSIS | COUNTS, GARY W | 1678 | §101§112 | Non-Final OA | — | Pending | Aug 21, 2024 |
| 18765731 | SYSTEMS AND METHODS FOR USING OLFACTORY STIMULI TO INFLUENCE A BEHAVIOR OR CONDITION OF A SUBJECT | DIETZ, NOE ROBERT | 3791 | §102§103 | Non-Final OA | — | Pending | Jul 08, 2024 |
| 18742139 | DRUG SCREENING METHOD AND MODEL FOR MONITORING PLATINUM-RESISTANT OVARIAN CANCER TUMOR GROWTH AND METASTASES | RAGHU, GANAPATHIRAM | 1652 | §102§103§112 | Final Rejection | — | Pending | Jun 13, 2024 |
| 18627146 | HYBRID GOLD NANOPARTICLE-LIPID NANOPARTICLES AND METHODS OF USE AND PRODUCTION THEREOF | SONG, JIANFENG | 1613 | §103 | Non-Final OA | — | Pending | Apr 04, 2024 |
| 18611339 | APPARATUS FOR TIME-RESOLVED FLUORESCENCE MEASUREMENT USING BANDWIDTH-LIMITED DIGITAL-PULSE LIGHT MODULATION AND METHODS | AMARA, MOHAMED K | 2877 | §103 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18444665 | System and Method for Locating Undocumented Orphaned Oil and Gas Wells with a Smartphone | SCHINDLER, DAVID M | 2858 | §101§103§112 | Final Rejection | 155d overdue | Pending | Feb 17, 2024 |
| 18428985 | Endoscopy Based on Optical Coherence Tomography (OCT) and Convolutional Neural Networks (CNNs) | BARKER, DAYTON HYUN JIN | 3795 | §103 | Final Rejection | — | Pending | Jan 31, 2024 |
| 18422556 | METHODS OF TREATING TRAUMATIC BRAIN INJURY AND RELATED NEUROLOGICAL CONDITIONS | VARADARAJ, ARCHANA | 1658 | §102§103§112DP | Non-Final OA | — | Pending | Jan 25, 2024 |
| 18579096 | TARGETED GLYCOSAMINOGLYCAN-PARTICLES AND METHODS OF USE | PALLAY, MICHAEL B | 1617 | §102§103§112 | Final Rejection | — | Pending | Jan 12, 2024 |
| 18394850 | COMPOSITIONS WITH DOPED TITANIUM DIOXIDE NANOPARTICLES AND METHODS OF USE | NILAND, PATRICK DENNIS | 1762 | §103Other | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18543655 | ISOMEROHYDROLASE INHIBITOR FOR TREATMENT OF ATROPHIC FORM OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE | BORALSKY, LUKE ALAN | 1624 | §103 | Non-Final OA | — | Pending | Dec 18, 2023 |
| 18037706 | Apparatus and Method for Capturing Aerosols | WILSON, KAYLEE R | 3700 | §103§112 | Final Rejection | 15d overdue | Pending | May 18, 2023 |
| 17971072 | MICROBIOME TRANSPLANTATION FOR OSTEOARTHRITIS THERAPY | CRUM, MARY ABOU NADER | 1657 | §103§112 | Final Rejection | 34d | Pending | Oct 21, 2022 |
| 17930505 | DEEP NEURAL NETWORKS FOR ESTIMATING POLYGENIC RISK SCORES | WHALEY, PABLO S | 3619 | §101§102§112 | Non-Final OA | — | Pending | Sep 08, 2022 |
| 17750113 | APPARATUS AND METHOD FOR CONTINUOUS SEPARATION OF SOLID PARTICLES FROM SOLID-LIQUID SLURRIES | GERMAIN, ADAM ADRIEN | 1777 | §103 | Final Rejection | 111d overdue | Pending | May 20, 2022 |
| 17534888 | SHIKIMATE ANALOGUES AND METHODS OF USE | SOROUSH, LAYLA | 1622 | §103 | Final Rejection | 53d overdue | Pending | Nov 24, 2021 |
| 17441869 | SURFACE-MODIFIED DOPED TITANIUM DIOXIDE NANOPARTICLES AND USES | PROSSER, ALISSA J | 1619 | §103§112Other | Final Rejection | — | Pending | Sep 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Board of Regents of the University of Oklahoma has 25 pending office actions as of October 2026, spread across 25 art units and 24 examiners.
Ding Y Tan has the most, with 2 of The Board of Regents of the University of Oklahoma's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
